Jpmorgan Chase & CO Astrazeneca PLC Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,247,633 shares of AZN stock, worth $396 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,247,633
Previous 5,322,687 1.41%
Holding current value
$396 Million
Previous $415 Million 17.1%
% of portfolio
0.03%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$63.2 - $79.58 $4.74 Million - $5.97 Million
-75,054 Reduced 1.41%
5,247,633 $344 Million
Q3 2024

Dec 26, 2024
BUY
$76.67 - $87.62 $80.4 Million - $91.9 Million
1,048,290 Added 24.52%
5,322,687 $415 Million
Q3 2024

Nov 08, 2024
BUY
$76.67 - $87.62 $80.4 Million - $91.9 Million
1,048,290 Added 24.52%
5,322,687 $415 Million
Q2 2024

Dec 26, 2024
SELL
$66.81 - $80.83 $70 Million - $84.7 Million
-1,048,290 Reduced 19.69%
4,274,397 $333 Million
Q2 2024

Aug 12, 2024
BUY
$66.81 - $80.83 $19.4 Million - $23.5 Million
290,546 Added 7.29%
4,274,397 $333 Million
Q1 2024

Dec 26, 2024
SELL
$61.03 - $69.57 $81.7 Million - $93.1 Million
-1,338,836 Reduced 25.15%
3,983,851 $270 Million
Q1 2024

May 10, 2024
BUY
$61.03 - $69.57 $26.9 Million - $30.7 Million
441,441 Added 12.46%
3,983,851 $270 Million
Q4 2023

Dec 26, 2024
SELL
$61.89 - $69.28 $110 Million - $123 Million
-1,780,277 Reduced 33.45%
3,542,410 $239 Million
Q4 2023

Feb 12, 2024
BUY
$61.89 - $69.28 $92.5 Million - $104 Million
1,494,899 Added 73.01%
3,542,410 $239 Million
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $1.89 Million - $2.09 Million
-29,081 Reduced 1.4%
2,047,511 $139 Million
Q2 2023

Aug 11, 2023
SELL
$69.91 - $75.81 $41 Million - $44.4 Million
-586,256 Reduced 22.02%
2,076,592 $149 Million
Q1 2023

May 11, 2023
SELL
$63.15 - $71.6 $42.6 Million - $48.3 Million
-674,329 Reduced 20.21%
2,662,848 $185 Million
Q4 2022

Feb 13, 2023
BUY
$54.21 - $70.44 $83.8 Million - $109 Million
1,545,443 Added 86.25%
3,337,177 $226 Million
Q3 2022

Nov 14, 2022
BUY
$53.02 - $135.75 $50.8 Million - $130 Million
958,359 Added 115.0%
1,791,734 $98.3 Million
Q2 2022

Aug 11, 2022
BUY
$59.26 - $71.14 $10 Million - $12 Million
169,380 Added 25.51%
833,375 $55.1 Million
Q1 2022

May 11, 2022
BUY
$55.72 - $67.12 $14.7 Million - $17.7 Million
263,929 Added 65.97%
663,995 $44 Million
Q4 2021

Feb 10, 2022
SELL
$54.02 - $63.83 $60.2 Million - $71.2 Million
-1,115,017 Reduced 73.59%
400,066 $23.3 Million
Q3 2021

Nov 12, 2021
BUY
$55.56 - $60.79 $84.2 Million - $92.1 Million
1,515,083 New
1,515,083 $91 Million

Others Institutions Holding AZN

# of Institutions
1,358
Shares Held
512M
Call Options Held
6.08M
Put Options Held
4.44M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $234B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email